Off-Patent Drugs Get UK Spotlight, But Picture Is Still ‘Nuanced’

HTA Body NICE Needs ‘Radical’ Change To Suit Generics & Biosimilars

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".